Archives of Toxicology

, 82:615 | Cite as

Cell protection induced by beta-sitosterol: inhibition of genotoxic damage, stimulation of lymphocyte production, and determination of its antioxidant capacity

  • R. Paniagua-Pérez
  • E. Madrigal-Bujaidar
  • S. Reyes-Cadena
  • I. Álvarez-González
  • L. Sánchez-Chapul
  • J. Pérez-Gallaga
  • N. Hernández
  • G. Flores-Mondragón
  • O. Velasco
Genotoxicity and Carcinogenicity

Abstract

Beta-sitosterol (BS) is a compound that has shown various activities potentially useful for human health. In the present study, we determined its antigenotoxic capacity and lymphocyte induction potential in mouse as well as its capacity to trap free radicals in vitro. BS, in doses from 200 to 1,000 mg/kg, was able to significantly reduce the frequency of sister chromatid exchanges induced by 10 mg/kg of doxorubicin (DX) in bone marrow cells. The same range of BS doses also gave rise to a strong reduction in the rate of micronucleated, polychromatic erythrocytes induced by DX. In addition, we determined an increase in the production of lymphocytes in mice administered with BS. By means of the DPPH assay, the compound was shown to trap free radicals in a concentration dependent manner as high as 78.12% using 250 μg/ml. Our research established three relevant biological activities of BS which show its potential as a chemopreventive agent.

Keywords

Beta-sitosterol Doxorubicin Antigenotoxicity Antioxidant 

References

  1. Aguilar JL, Rojas P, Marcelo A, Plaza A, Bauer R, Reininger E, Klaas CA, Merfort I (2002) Anti-inflammatory activity of two different extracts of Uncaria tomentosa (Rubiaceae). J Ethnopharmacol 81:271–276PubMedCrossRefGoogle Scholar
  2. Antolovich M, Prenzler PD, Patsalides E, McDonald S, Robards K (2002) Methods for testing antioxidant activity. Analyst 127:183–198PubMedCrossRefGoogle Scholar
  3. Awad AB, Fink CS (2000) Phytosterols as anticancer dietary components: evidence and mechanism of action. J Nutr 130:2127–2130PubMedGoogle Scholar
  4. Awad AB, von Holtz RL, Cone JP, Fink CS, Chen YC (1998) beta-Sitosterol inhibits the growth of HT-29 human colon cancer cells by activating the sphingomyelin cycle. Anticancer Res 18:471–479PubMedGoogle Scholar
  5. Berges RR, Windeler J, Trampisch HJ, Senge T (1995) Randomised, placebo-controlled, double-blind clinical trial of beta-sitosterol in patients with benign prostatic hyperplasia. Beta-sitosterol Study Group. Lancet 345:1529–1532PubMedCrossRefGoogle Scholar
  6. Berges RR, Kassen A, Senge T (2000) Treatment of symptomatic benign prostatic hyperplasia with beta-sitosterol: an 18-month follow-up. BJU Int 85:842–846PubMedCrossRefGoogle Scholar
  7. Bouic PJ (2001) The role of phytosterols and phytosterolins in immune modulation: a review of the past 10 years. Curr Opin Clin Nutr Metab Care 4:471–475PubMedCrossRefGoogle Scholar
  8. Bouic PJ, Etsebeth S, Leibenberg RW, Albrecht CF, Pegel K, Van Jaarsveld PP (1996) beta-Sitosterol and beta-sitosterol glucoside stimulate human peripheral blood lymphocyte proliferation: implications for their use as an immunomodulatory vitamin combination. Int J Immunopharmacol 18:693–700PubMedCrossRefGoogle Scholar
  9. Bouic PJ, Clark A, Lamprecht J, Freestone M, Pool EJ, Liebenberg RW, Kotze D, van Jaarsveld PP (1999) The effects of B-sitosterol (BSS) and B-sitosterol glucoside (BSSG) mixture on selected immune parameters of marathon runners: inhibition of post marathon immune suppression and inflammation. Int J Sports Med 20:258–262PubMedCrossRefGoogle Scholar
  10. Breytenbach U, Clark A, Lamprecht J, Bouic P (2001) Flow cytometric analysis of the Th1–Th2 balance in healthy individuals and patients infected with the human immunodeficiency virus (HIV) receiving a plant sterol/sterolin mixture. Cell Biol Int 25:43–49PubMedCrossRefGoogle Scholar
  11. Chen HC (2001) Molecular mechanisms of sterol absorption. J Nutr 131:2603–2605PubMedGoogle Scholar
  12. Delaporte RH, Sarragiotto MH, Takemura OS, Sanchez GM, Filho BP, Nakamura CV (2004) Evaluation of antioedematogenic free radical scavenging and antimicrobial activities of aerial parts of Tillandisiastreptocarpa Baker-Bromeliaceae. J Ethnopharmacol 95:229–233PubMedCrossRefGoogle Scholar
  13. Gorinstein S, Martin-Belloso O, Katrich E, Lojek A, Cìz M, Gligelmo-Miguel N, Harnenkit R, Park YS, Jung ST, Trakhtenberg S (2003) Comparison of the contents of the main biochemical compounds and the antioxidant activity of some Spanish olive oils as determined by four different radical scavenging test. J Nutr Biochem 14:154–159PubMedCrossRefGoogle Scholar
  14. Gupta MB, Nath R, Srivastava N, Shanker K, Kishor K, Bhargava KP (1980) Anti-inflammatory and antipyretic activities of beta-sitosterol. Planta Med 39:157–163PubMedGoogle Scholar
  15. Han C, Ding H, Casto B, Stoner GD, D’Ambrosio SM (2005) Inhibition of the growth of premalignant and malignant human oral cell lines by extracts and components of black raspberries. Nutr Cancer 51:207–217PubMedCrossRefGoogle Scholar
  16. Haydn Pritchard P, Li M, Zamfir C, Lukic T, Novak E, Moghadasian MH (2003) Comparison of cholesterol-lowering efficacy and anti-atherogenic properties of hydrogenated versus non-hydrogenated (Phytrol™) tall oil-derived phytosterols in apo E-deficient mice. Cardiovasc Drugs Ther 17:443–449PubMedCrossRefGoogle Scholar
  17. Hendriks HF, Brink EJ, Meijer GW, Princen HM, Ntanios FY (2003) Safety of long-term consumption of plant sterol esters-enriched spread. Eur J Clin Nutr 57:681–692PubMedCrossRefGoogle Scholar
  18. Hernandez-Ceruelos A, Madrigal-Bujaidar E, de la Cruz C (2004) Inhibitory effect of chamomile essential oil on the sister chromatid exchanges induced by daunorubicin and methyl methanesulfonate in mouse bone marrow. Toxicol Lett 135:103–110CrossRefGoogle Scholar
  19. Jayaprakasha GK, Mandadi KK, Poulose SM, Jadegoud Y, Nagana Gowda GA, Patil BS (2007) Inhibition of colon cancer cell growth and antioxidant activity of bioactive compounds from Poncirus trifoliata (L.) Raf. Bioorg Med Chem 15:4923–4932PubMedCrossRefGoogle Scholar
  20. Ju YH, Claussen LM, Allred KF, Almada AL, Helferich WG (2004) Beta-sistosterol, beta-sistoterol glucoside, and a mixture of beta-sitosterol and beta-sitosterol glucoside modulate the growth of estrogen-responsive breast cancer cells in vitro and in ovariectomized athymic mice. J Nutr 134:1139–1144Google Scholar
  21. Kassen A, Berges R, Senge T (2000) Effect of beta-sitosterol on transforming growth factor-beta-1 expression and translocation protein kinase C alpha in human prostate stromal cells in vitro. Eur Urol 37:735–741PubMedCrossRefGoogle Scholar
  22. Keplinger K, Laus G, Wurm M, Dierich MP, Teppner H (1999) Uncaria tomentosa (Willd.) DC.––ethnomedicinal use and new pharmacological, toxicological and botanical results. J Ethnopharmacol 64:23–34PubMedCrossRefGoogle Scholar
  23. Khan MA, Mustafa J, Musarrat J (2003) Mechanism of DNA strand breakage induced by photosensitized tetracycline–Cu(II) complex. Mutat Res 525:109–119PubMedGoogle Scholar
  24. Klippel KF, Hiltl DM, Schipp B (1997) A multicentric, placebo-controlled, double-blind clinical trial of beta-sitosterol (phytosterol) for the treatment of benign prostatic hyperplasia. German BPH-Phyto Study group. Br J Urol 80:427–432PubMedGoogle Scholar
  25. Kocak N, Ustun H, Gulkac MD, Kanli AO, Borazan A, Yilmaz A (2004) Effects of 10alpha,25-dihydroxyvitamin D3 on doxorubicin-induced chromosomal aberrations in rat bone marrow cells. Acta Oncol 43:204–208PubMedCrossRefGoogle Scholar
  26. Lim JC, Park JH, Budesinsky M, Kasal A, Han YH, Koo BS, Lee SI, Lee DU (2005) Antimutagenic constituents from the thorns of Gleditsia sinensis. Chem Pharm Bull 53:561–564PubMedCrossRefGoogle Scholar
  27. Ling WH, Jones PJ (1995) Dietary phytosterols: a review of metabolism, benefits and side effects. Life Sci 57:195–206PubMedCrossRefGoogle Scholar
  28. Madrigal-Santillán E, Madrigal-Bujaidar E, Marquez-Marquez R, Reyes A (2006) Antigenotoxic effect of Saccharomyces cereviciae on the damage produced in mice fed with aflatoxin B(1) contaminated corn. Food Chem Toxicol 44:2058–2063PubMedCrossRefGoogle Scholar
  29. Melichar B, Tousková M, Dvorák J, Jandik P, Kopecký O (2001) The peripheral blood leukocyte phenotype in patients with breast cancer: effect of doxorubicin/paclitaxel combination chemotherapy. Immunopharmacol Immunotoxicol 23:163–173PubMedCrossRefGoogle Scholar
  30. Mizutani H, Oikawa S, Hiraku Y, Murata M, Kojima M, Kawanishi M (2003) Distinct mechanisms of site-specific oxidative DNA damage by doxorubicin in the presence of copper (II) and NADPH-cytochrome P450 reductase. Cancer Sci 94:686–691PubMedCrossRefGoogle Scholar
  31. Ovesna Z, Vachalkova A, Horvathova K (2004) Taraxasterol and beta-sitosterol: new naturally compounds with chemoprotective/chemopreventive effects. Neoplasma 51:407–414PubMedGoogle Scholar
  32. Paniagua-Perez R, Madrigal-Bujaidar E, Reyes CS, Perez GJ, Velasco MO, Molina D (2002) Sister chromatid exchanges produced by imipramine and desipramine in mouse bone marrow cells treated in vivo. Toxicol Lett 132:123–129PubMedCrossRefGoogle Scholar
  33. Paniagua-Perez R, Madrigal-Bujaidar E, Reyes-Cadena S, Molina-Jasso D, Gallaga JP, Silva-Miranda A, Velazco O, Hernández N, Chamorro G (2005) Genotoxic and cytotoxic studies of Beta-sitosterol and pteropodine in mouse. J Biomed Biotechnol 2005:242–247PubMedCrossRefGoogle Scholar
  34. Park KY, Jung KD, Rhee SH, Choi YH (2003) Antimutagenic effects of doenjang (Koren fermented soypaste) and its active compounds. Mutat Res 523–524:43–53PubMedGoogle Scholar
  35. Pegel KI (1997) The importance of sitosterol and sitosterolin in human and animal nutrition. S Afr J Sci 93:263–268Google Scholar
  36. Raicht RF, Cohen BI, Fazzini EP, Sarwal AN, Takahashi M (1980) Protective effect of plant sterols against chemically induced colon tumors in rats. Cancer Res 40:403–405PubMedGoogle Scholar
  37. Rizzi R, Re F, Bianchi A, De Feo V, de Simone F, Bianchi L, Stivala LA (1993) Mutagenic and antimutagenic activities of Uncaria tomentosa and its extracts. J Ethnopharmacol 38:63–77PubMedCrossRefGoogle Scholar
  38. Romero-Jimenez M, Campos-Sanchez J, Analla M, Muñoz-Serrano A, Alonso-Moraga A (2005) Genotoxicity and anti-genotoxicity of some traditional medicinal herbs. Mutat Res 585:147–155PubMedGoogle Scholar
  39. Russo A, Aquaviva R, Campisi A, Sorrenti V, Di Giacomo C, Virgata G, Barcellona ML, Vanilla A (2000) Bioflavonoids as antiradicals, antioxidants and DNA cleavage protectors. Cell Biol Toxicol 16:91–98PubMedCrossRefGoogle Scholar
  40. Sarkar A, Saha BK, Basak R, Mukhopadhyay I, Karmakar R, Chatterjee M (2000) Anticlastogenic potential of 1alpha,25-dihydroxyvitamin D3 in murine lymphoma. Cancer Lett 150:1–13PubMedCrossRefGoogle Scholar
  41. Snyder RD, Gillies PJ (2002) Evaluation of the clastogenic, DNA intercalative, and topoisomerase II-interactive properties of bioflavonoids in Chinese hamster V79 cells. Environ Mol Mutagen 40:266–276PubMedCrossRefGoogle Scholar
  42. Takemura G, Fujiwara H (2007) Doxorubicin-induced cardiomyophaty from the cardiotoxic mechanisms to management. Prog Cardiovasc Dis 49:330–352PubMedCrossRefGoogle Scholar
  43. Takeoka GR, Dao LT (2003) Antioxidant constituents of almond [Prunus dulcis (Mill.) D. A. Webb] hulls. J Agric Food Chem 51:496–501PubMedCrossRefGoogle Scholar
  44. Tapiero H, Townsend DM, Tew KD (2003) Phytosterols in the prevention of human pathologies. Biomed Pharmacother 57:321–325PubMedCrossRefGoogle Scholar
  45. Villaseñor IM, Lemon P, Palileo A, Bremner JB (1996) Antigenotoxic spinasterol from Cucurbita maxima flowers. Mutat Res 360:89–93PubMedGoogle Scholar
  46. Villaseñor IM, Angelada J, Canlas AP, Echegoyen D (2002) Bioactivity studies on beta-sitosterol and its glucoside. Phytother Res 16:417–421PubMedCrossRefGoogle Scholar
  47. Vivancos M, Moreno JJ (2005) beta-Sitosterol modulates antioxidant enzyme response in RAW 264.7 macrophages. Free Radic Biol Med 39:91–97PubMedCrossRefGoogle Scholar
  48. von Holtz RL, Fink CS, Awad AB (1998) beta-Sitosterol activates the sphingomyelin cycle and induces apoptosis in LNCaP human prostate cancer cells. Nutr Cancer 32:8–12CrossRefGoogle Scholar
  49. Zhang XY, Li WG, Wu YJ, Gao MT (2005a) Amelioration of doxorubicin-induced myocardial oxidative stress and immunosuppression by grape seed proanthocyanidins in tumor-bearing mice. J Pharm Pharmacol 57:1043–1052PubMedCrossRefGoogle Scholar
  50. Zhang XY, Li WG, Wu YJ, Zehng TZ, Li W, Qu SY, Liu NF (2005b) Protoanthocyanidin from grape seeds potentiates anti-tumor activity of doxorubicin via immunomodulatory mechanism. Int Immunopharmacol 5:1247–1257PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2008

Authors and Affiliations

  • R. Paniagua-Pérez
    • 1
  • E. Madrigal-Bujaidar
    • 2
  • S. Reyes-Cadena
    • 1
  • I. Álvarez-González
    • 2
  • L. Sánchez-Chapul
    • 1
  • J. Pérez-Gallaga
    • 1
  • N. Hernández
    • 1
  • G. Flores-Mondragón
    • 1
  • O. Velasco
    • 1
  1. 1.Laboratorio de Bioquímica MuscularInstituto Nacional de RehabilitaciónMexico, D.F.Mexico
  2. 2.Laboratorio de GenéticaEscuela Nacional de Ciencias Biológicas, I.P.N.Mexico, D.F.Mexico

Personalised recommendations